Loading...

Boston Scientific Corporation

BSX-PANYSE
Healthcare
Medical - Devices
$122.18
$2.83(2.37%)

Boston Scientific Corporation (BSX-PA) Stock Overview

Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.7/100

Key Financials

Market Cap175.4B
P/E Ratio75.42
EPS (TTM)$0.53
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$170.39

BSX-PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Boston Scientific Corporation (BSX-PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $170.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 75.42 and a market capitalization of 175.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;